Newborn and Infant Nursing Reviews
Volume 7, Issue 3 , Pages 131-142 , September 2007

Neonatal Short Bowel Syndrome

  • Jennifer B. Harris, RNC, MSN, NNP

      Affiliations

    • Corresponding Author InformationAddress correspondences to Jennifer B. Harris, RNC, MSN, NNP, Department of Pediatrics, College of Medicine, University of Florida, PO Box 100296, Gainesville, FL 32610.

References 

  1. Goulet O, Sauvat F. Short bowel syndrome and intestinal transplantation in children. Curr Opin Clin Nutr Metab Care. 2006;9:304–313
  2. Treem WR. Short bowel syndrome. In:  Wyllie R,  Hyams JS editor. Pediatric gastrointestinal disease: pathophysiology, diagnosis, management. 2nd ed.. Philadelphia (PA): WB Saunders Company; 1999;p. 315–333
  3. Spencer AU, Neaga A, West B, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005;242:403–412
  4. Georgeson KE, Breaux CW. Outcome and intestinal adaptation in neonatal short-bowel syndrome. J Pediatr Surg. 1992;27:344–348
  5. Schalamon J, Schober PH, Gallippi P, Matthyssens L, Hollworth ME. Congenital short bowel: a case study and review of the literature. Eur J Pediatr Surg. 1999;9:248–250
  6. Wales PW, de Silva N, Kim JH, Leece L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005;40:755–762
  7. Wales PW, de Silva N, Kim J, Leece L, To T, Moore A. Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. J Pediatr Surg. 2004;39:690–695
  8. Goulet O. Short-bowel syndrome. In:  Guandalini S editors. Textbook of pediatric gastroenterology and nutrition. Boca Raton (FL): Taylor & Francis Group; 2004;p. 461–478
  9. Kurkchubasche AG, Rowe MI, Smith SD. Adaptation in 728 short-bowel syndrome: reassessing old limits. J Pediatr Surg. 1993;28:1069–1071
  10. Wilmore DW. Factors correlating with successful outcome following extensive intestinal resection in newborn infants. J Pediatr. 1972;80:88–95
  11. Bryant J. Observations on the growth and length of the human intestine. Am J Med Sci. 1924;167:499–520
  12. Siebert JR. Small intestine length in infants and children. Am J Dis Child. 1980;134:593–595
  13. Touloukian RJ, Walker G, Smith J. Normal intestinal length in preterm infants. J Pediatr Surg. 1983;18:720–723
  14. Borgstrom B, Dahlqvist A, Lundh G, Sjovall J. Studies of intestinal digestion and absorption in the human. J Clin Invest. 1957;36:1521–1536
  15. Vanderhoof JA. Short-bowel syndrome and intestinal adaptation. In:  Walker WA,  Durie PR,  Hamilton JR editor. Pediatric gastrointestinal disease. Lewiston (NY): B. C. Decker Inc; 2000;p. 583–603
  16. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am J Clin Nutr. 1996;64:222–231
  17. Allard JP, Jeejeebhoy KN. Nutritional support and therapy in the short bowel syndrome. Gastroenterol Clin. 1989;18:589–601
  18. Sacks AI, Warwick GJ, Barnard JA. Early proliferative events following intestinal resection in the rat. J Pediatr Gastroenterol Nutr. 1995;21:158–164
  19. Chaves M, Smith MW, Williamson RC. Increased activity of digestive enzymes in ileal enterocytes adapting to proximal bowel resection. Gut. 1987;28:981–987
  20. Hanson WR, Osborne JW, Sharp JG. Compensation by the residual intestine after intestinal resection in the rat. II. Influence of postoperative time interval. Gastroenterologia. 1977;72:701–705
  21. Jackson CS, Buchman AL. The nutritional management of short bowel syndrome. Nutr Clin Care. 2004;7:114–121
  22. Feldman EJ, Dowling RH, McNaughton H, Peters TJ. Effects of oral versus intravenous nutrition on intestinal adaptation after small bowel resection in the dog. Gastroenterologia. 1976;70:712–719
  23. Scolapio JS, Fleming R. Short bowel syndrome. Gastroenterol Clin North Am. 1998;27:467–479
  24. Niinikoski H, Stoll B, Guan X, et al. Onset of small intestinal atrophy is associated with reduced intestinal blood flow in TPN-fed neonatal piglets. J Nutr. 2004;134:1467–1474
  25. Sukhotnik I, Siplovich L, Shiloni E, Mor-Vatknin N, Harmon CM, Coran AG. Intestinal adaptation in short-bowel syndrome in infants and children: a collective review. Pediatr Surg Int. 2002;18:258–263
  26. Weser E, Babbitt J, Hoban M. Intestinal adaptation: different growth responses to disaccharides compared with monosaccharides in rat small bowel. Gastroenterology. 1986;91:1521–1527
  27. Lentze MJ. Intestinal adaptation in short-bowel syndrome. Eur J Pediatr. 1989;148:294–299
  28. Vanderhoof JA, Grandjean CJ, Kaufman SS, et al. Effect of high-percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr. 1984;8:685–698
  29. Vanderhoof JA, Grandjean CJ, Burkley KT, Antonson DL. Effect of casein versus casein hydrolysate on mucosal adaptation following massive bowel resection in infant rats. J Pediatr Gastroenterol Nutr. 1984;3:262–267
  30. Wales PW. Surgical therapy for short bowel syndrome. Pediatr Surg Int. 2004;20:647–657
  31. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology. 2003;124:1111–1134
  32. Nightingale JK, Kamm MA, Van der Sijp JR, Ghatei MA, Bloom SR, Lennard-Jones JE. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be “colonic brake” to gastric emptying. Gut. 1996;39:267–272
  33. Jeppesen PB, Hartman B, Thulesen J, et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short bowel patients with no colon. Gastroenterology. 2001;120:806–815
  34. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B. Low-dose growth hormone in adult home parenteral nutrition–dependent short bowel patients: a positive study. Gastroenterology. 2003;124:293–302
  35. Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg. 2005;40:763–768
  36. Lemmey AB, Ballard FJ, Martin AA, Howarth GS, Read LC. Treatment with IGF-1 peptides improves function of the remnant gut following small bowel resections in rats. Growth Factors. 1994;10:243–252
  37. Johnson LR, Lichtenberger LM, Copeland EM, Dudrick SJ, Castro GA. Action of gastrin on gastrointestinal structure and function. Gastroenterology. 1975;68:1184–1192
  38. Evers BM, Izukura M, Chung DH, et al. Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology. 1992;103:86–91
  39. Hughes CA, Bates T, Dowling RH. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog. Gastroenterology. 1978;75:34–41
  40. Palmer RH. Bile acids, liver injury, and liver disease. Arch Intern Med. 1972;130:606–617
  41. Wolf A, Pohlandt F. Bacterial infection: the main cause of acute cholestasis in newborn infants receiving short term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1989;8:297–303
  42. Braxton C, Lowry SF. Parenteral nutrition and liver dysfunction—new insight?. JPEN. 1995;19:3–4
  43. Kaufman SS, Loseke CA, Lupo JV, et al. Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome. J Pediatr. 1997;131:356–361
  44. Forchielli ML, Walker WA. Nutritional factors contributing to the development of cholestasis during total parenteral nutrition. Dev Pediatr. 2003;50:245–267
  45. Sondheimer JM, Asturias E, Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998;27:131–137
  46. DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: part 2. Am J Gastroenterol. 2004;99:1823–1832
  47. Merritt RJ. Cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr. 1986;5:9–22
  48. Hwang ST, Shulman RJ. Update on management and treatment of short gut. Clin Perinatol. 2002;29:181–194
  49. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525–532
  50. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006;130:S16–S28
  51. DeMarco G, Sordino D, Bruzzese E, et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther. 2006;24:387–394
  52. Uribarri J, Oh M, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998;77:73–82
  53. Buchman AL. Short bowel syndrome. In:  Feldman M,  Friedman LS,  Brandt LJ editor. Sleisenger and Fordtran's gastrointestinal and liver disease: pathophysiology/diagnosis/management. Philadelphia (PA): Saunders Elsevier; 2006;p. 2257–2276
  54. Hyman PE, Everett SL, Harada T. Gastric acid hypersecretion in short bowel syndrome in infants: association with extent of resection and enteral feeding. J Pediatr Gastroenterol Nutr. 1986;5:191–197
  55. Jacobsen K, Ladefoged K, Stage JG, Jarnum S. Effects of cimetidine on jejunostomy effluents in patients with severe short syndrome. Scand J Gastroenterol. 1986;21:824–828
  56. Nightingale JM, Walker ER, Farthing MJ, Lennard-Jones JE. Effect of omeprazole on intestinal output in the short bowel syndrome. Aliment Pharmacol Ther. 1991;5:405–412
  57. Jeppeson PB, Staun M, Tjellesen L, Mortensen PB. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut. 1998;43:763–769
  58. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroent. 2001;96:1494–1498
  59. Rosen GH. Somatostatin and its analogues in the short-bowel syndrome. Nutr Clin Pract. 1992;7:81–85
  60. Vanderhoof JA, Young RJ, Thompson JS. New and emerging therapies for short bowel syndrome in children. Pediatr Drugs. 2003;5:525–531
  61. Fried M, Siegrist H, Frei R, et al. Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut. 1994;35:23–26
  62. Williams NS, Evans P, King RF. Gastric acid secretion and gastrin production in short bowel syndrome. Gut. 1985;26:914–919
  63. Tsai S, Strouse PJ, Drongowski SI, Islam S, Teitelbaum DH. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. J Pediatr Surg. 2005;40:263–267
  64. Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parental nutrition induced biliary sludge in humans. Surg Gynecol Obstet. 1990;170:25–31
  65. Chadwick VS, Modha K, Dowling RH. Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med. 1973;289:172–176
  66. Barilla DE, Notz C, Kennedy D, Pak CY. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and absorptive hypercalciurias. Effect of calcium and magnesium. Am J Med. 1978;64:579–585
  67. Piedra PA, Dryja DM, LaScolea LJ. Incidence of catheter-associated gram negative bacteremia in children with short bowel syndrome. J Clin Microbiol. 1989;27:1317–1319
  68. Nahata MC, King DR, Powell DA, Mary SM, Ginn-Pease ME. Management of catheter-related infections in pediatric patients. JPEN J Parenter Enteral Nutr. 1988;12:58–59
  69. Vanderhoof JA, Langnas AN. Short bowel syndrome in children and adults. Gastroenterology. 1997;113:1767–1778
  70. Mokete B, DeCock R. Xerophthalmia and short bowel syndrome. Br J Gastroenterol. 1998;82:1340–1341
  71. Stamp TC, Round JM. Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature. 1974;247:563–565
  72. Haddad JG, Hahn TJ. Natural and synthetic sources of 25-hydroxyvitamin D in man. Nature. 1973;244:515–517
  73. Fritsma GA. Vitamin E and autooxidation. Am J Med Technol. 1983;49:453–456
  74. Tanyel MC, Mancano LD. Neurologic findings in vitamin E deficiency. Am Fam Physician. 1997;55:197–201
  75. Conly JM, Stein K, Worobetz L, Rutledge-Harding S. The contribution of vitamin K2(menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994;89:915–923
  76. Anderson H, Bosaeus I, Brummer RJ, et al. Nutritional and metabolic consequences of extensive bowel resection. Dig Dis. 1986;4:193–202
  77. Ellegard L, Bosaeus I, Nordgren S, et al. Low-dose growth recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg. 1997;225:88–96
  78. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998;14:158–164
  79. Gura KM, Duggan CP, Collier SB, et al. Reversal of parenteral nutrition–associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006;118:e197–e201
  80. Alwayn IP, Gura K, Nose V, et al. Omega 3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005;57:445–452
  81. Johnson T, Sexton E. Managing children and adolescents on parenteral nutrition: challenges for the nutritional support team. Proc Nutr Soc. 2006;65:217–221
  82. Andorsky DJ, Dennis DP, Lillebei CW, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001;139:27–33
  83. Utter SL, Jaksic T, Duggan C. Gastrointestinal disorders. Part 7: short bowel syndrome. In:  Hansen A,  Puder M editor. Manual of neonatal surgical intensive care. Hamilton (ON): BC Decker Inc; 2003;p. 284–299
  84. Parker P, Stroop S, Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Clin Invest. 1981;67:360–364
  85. Xanthou M, Bines J, Walker WA. Human milk and intestinal host defense in newborns: an update. Adv Pediat. 1995;42:171–208
  86. Ameen VZ, Powell GK, Jones LA. Quantitation of fecal carbohydrate excretion in patients with short bowel syndrome. Gastroenterology. 1987;92:493–500
  87. Bianchi A. Longitudinal intestinal lengthening and tailoring: results in 20 children. J R Soc Med. 1997;90:429–432
  88. Walker SR, Nucci A, Yaworski JA, Barksdale EM. The Bianchi procedure: a 20 year single institution experience. J Pediatr Surg. 2006;41:113–119
  89. Thompson JS, Pinch LW, Young R, Vanderhoof JA. Long term outcome of intestinal lengthening. Transplant Proc. 2000;32:12242–12243
  90. Modi BP, Javid PJ, Jaksic T, et al. First report of the international serial transverse enteroplasty registry: indications, efficacy and complications. J Am Coll Surg. 2007;204:365–371
  91. Thompson JS, Rikkers LF. Surgical alternatives for the short bowel syndrome. Am J Gastroenterol. 1987;82:97–106
  92. Thompson JS. Surgical approach to short bowel: procedures to slow intestinal transit. Eur J Pediatr Surg. 1999;9263–9266
  93. Thompson JS. Surgical rehabilitation of intestine in short bowel syndrome. Surgery. 2004;135:465–470
  94. Panis Y, Messing B, Rivet P, et al. Segmental reversal of the small bowel as an alternative to intestinal transplantation in patients with short bowel syndrome. Ann Surg. 1997;225:401–407
  95. Kato T, Tzakis AG, Selvaggi G, et al. Intestinal and multivisceral transplantation in children. Ann Surg. 2006;243:756–764
  96. Ghanekar A, Grant D. Small bowel transplantation. Curr Opin Crit Care. 2001;7:133–137
  97. Dove L, Brown R. The emerging role of gastrointestinal organ transplantation. Clin Fam Pract. 2004;6:775–791
  98. Mueller A, Pascher A, Platz K, et al. Modified surgical technique in clinical small bowel transplantation: donor and recipient management. Transplant Proc. 2002;34:2265–2267
  99. Cicalese L, Seleri P, Green M, Abu-Elmagd K, Kocoshis S, Reyes J. Bacterial translocation in clinical intestinal transplantation. Transplantation. 2001;71:1414–1417
  100. 2000 Annual Report. The U.S. Scientific Registry of Transplant Recipients and The Organ Procurement and Transplantation Network. Transplant data 1990-1999. U.S. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD: United Network of Organ Sharing, Richmond V.A.
  101. Beath SV, Needham SJ, Kelly DA, et al. Clinical features and prognosis of children assessed for isolated small bowel or combined bowel and liver transplantation. J Pediatr Surg. 1997;32:459–461
  102. Cicalese L, Sileri P, Asolati M, Rastellini C, Abcarian H, Benedetti E. Low infectious complications in segmental living related transplantation in adults. Clin Transplantation. 2000;14:567–571
  103. Testa G, Panaro F, Schena S, Hollerman M, Abcarian H, Benedetti E. Living related small status in short bowel patients with no colon. Gastroenterology. 2001;120:806–815
  104. Byrne A, Morrissey TB, Nattakom TV, Ziegler TR, Wilmore DW. Growth hormone, glutamine, and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN J Parenter Enteral Nutr. 1995;19:296–302
  105. Byrne AB, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome. Ann Surg. 2005;242:655–661
  106. Scolapio JS, Camilleri M, Fleming CR, et al. Effect of growth hormone, glutamine, and diet on adaptation in short bowel syndrome: a randomized, controlled study. Gastroenterology. 1997;113:1074–1081
  107. Ellegard L, Bosaeus I, Nordgren S, Bengtsson BA. Low-dose growth recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg. 1997;225:88–96
  108. Szkudlarek J, Jeppesen PB, Mortensen PB. Effect of high-dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomized, double-blind, crossover, placebo controlled study. Gut. 2000;47:199–205
  109. Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54:1224–1231
  110. Cohen S, Taylor JM. Epidermal growth factor: chemical and biological characterization. Recent Prog Horm Res. 1974;30:533–550
  111. Choi RS, Vacanti JP. Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc. 1997;29:848–851
  112. Choi RS, Pothoulakis C, Kim BS, Mooney D, Vacanti M, Vacanti JP. Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. Pediatr Surg. 1998;33:991–997
  113. Grikscheit TC, Siddique A, Ochoa ER, et al. Tissue-engineered small intestine improves recovery after small bowel resection. Ann Surg. 2004;240:748–754

PII: S1527-3369(07)00071-2

doi: 10.1053/j.nainr.2007.06.005

Newborn and Infant Nursing Reviews
Volume 7, Issue 3 , Pages 131-142 , September 2007

Article Tools

* Image Usage & Resolution